Production Of Cell Therapy Products Under GMP Regulations
Emerging cell therapies aim to produce cell populations for clinical indications such as cancer, autoimmune and cardiovascular diseases. As hospitals and translational institutions explore implementing this technology, they are simultaneously evaluating whether to manufacture cell therapy products on-site. Manufacturing transitions require adherence to current Good Manufacturing Practice (cGMP) to ensure that treatments are safe and […]
Production Of Cell Therapy Products Under GMP Regulations Read More »